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Abstract
Rheumatic heart disease (RHD) is a chronic, non-communicable disease presently found
in developing countries throughout the world. Many different social, cultural, and physical
conditions affect the locations of RHD case occurrence. It was a leading cause of death in the
United States among 5-20 year olds in the early twentieth century. By the 1960s, the rate
dropped to just above 0%. However, rheumatic heart disease continues to be a major health issue
worldwide. 233,000 individuals die from RHD each year and there are 15-30 million cases
currently among children and young adults. This disease is characterized by cardiac
inflammation and mitral valve stenosis, a disorder in which the mitral valve does not fully open.
Rheumatic heart disease is a direct result of an onset of rheumatic fever caused by untreated strep
throat. Children and adolescents are susceptible to rheumatic fever after contracting pharyngitis
with group A beta-hemolytic streptococcus bacteria. Rheumatic fever results from an
autoimmune reaction with the group A streptococci approximately 1-3 weeks after the initial
onset of pharyngitis resulting in cardiac inflammation. The innate and adaptive immune
responses in the body cause the streptococcal proteins to displays molecular mimicry in the form
of bacterial M-proteins. Research has shown that Th17 cell-associated cytokines might play an
important role in the pathophysiology of the development of rheumatic heart disease (Luiza

Guilherme et al., 2004). Emerging therapies are being developed that are aimed toward
preventing the onset rheumatic heart disease. Antibiotics and other medications can be
distributed to these patients but certain factors complicate the management of this treatment
option. There are surgical options available for the treatment of RHD, however some countries
do not have access to this form of treatment and often times patients end up needing additional
operations.
In the twenty first-century, the most significant barriers that health professionals and
public health officers face regarding the prevalence of rheumatic heart disease in developing
countries are limited access to health care, under-diagnosis of early stages of infection, no
vaccination against group A streptococcus bacteria, and a lack of reproductive resources for
pregnant women with rheumatic heart disease. RHD occurs predominantly in females and it can
be passed down genetically. These countries need adequate prophylaxis distribution and
management options, therapies for treatment with monitoring and proper control, opportunities
for surgical interventions when necessary, reproductive resources for women with RHD, and
additional measures for prevention of RHD in children and adolescents. The future research that
will be discussed in this thesis will cover what can be done to reduce the prevalence of RHD in
developing countries.
The research presented in this thesis will outline the current management of rheumatic
heart disease in light of worldwide occurrences of the disease. I have recommended six key
interventions that aim to monitor, control, prevent, educate health professionals, and conduct
further research for the eradication of rheumatic heart disease in the twenty first century. All
recommendations will be based upon previously published literature and global studies.

Christian Worldview Integration
My research design is a literature review with theoretical recommendations based on
primary sources of research and literature. Rheumatic heart disease is an eye-opening condition
because it clearly displays the health disparities that these poorer countries face compared to the
developed world. Matthew 28:19-20 says, “Therefore go and make disciples of all nations,
baptizing them in the name of the Father and of the Son and of the Holy Spirit, and teaching
them to obey everything I have commanded you. And surely I am with you always, to the very
end of the age.” In the same way that Christians should deliver the Gospel to the ends of the
Earth, health professionals should take the technology and advancements in medicine that we
have in the Western world to these developing countries to save many of their lives.
In John 9, the disciples are walking with Jesus and they see a man who was born blind.
They asked Jesus if God punished this man with blindness because of a terrible sin he committed
or perhaps because of a sin committed by his parents. Jesus tells them that neither is the case. In
fact, He tells them that the man was born blind so that God’s glory could be shown to the world.
Jesus then heals the man and restores his sight. He goes and tells all of his neighbors what Jesus
has done for Him. This story is my inspiration for pursuing a career in medicine. God’s glory is
revealed when someone is healed from a disease that could have taken their life. The people in
developing countries need medical treatment and the good news of the salvation that they can
have through Jesus Christ.
This research is impactful for students, Christians, and health professionals who can be
involved in providing care both physically and spiritually for those who are suffering from
medical conditions such as rheumatic heart disease in developing countries.

